Clinical Trials
160
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (148 trials with phase data)• Click on a phase to view related trials
SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2019-01-29
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 4
- Registration Number
- NCT03820544
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Decision Counseling Program in Increasing Shared Decision Making and Clinical Trial Participation in Patients With Stage 0-IV Lung Cancer (Free to Breathe)
- Conditions
- Lung Cancer
- First Posted Date
- 2019-01-29
- Last Posted Date
- 2025-04-29
- Target Recruit Count
- 44
- Registration Number
- NCT03820557
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
- Conditions
- Prostate Cancer
- First Posted Date
- 2019-01-17
- Last Posted Date
- 2025-05-15
- Target Recruit Count
- 241
- Registration Number
- NCT03807492
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
- Conditions
- Stage 0 Colorectal Cancer AJCC v8Stage I Colorectal Cancer AJCC v8Stage IIB Colorectal Cancer AJCC v8Stage IIIA Colorectal Cancer AJCC v8Colorectal AdenomaStage II Colorectal Cancer AJCC v8Stage IIC Colorectal Cancer AJCC v8Stage IIIB Colorectal Cancer AJCC v8Stage IIA Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8
- Interventions
- Other: Placebo
- First Posted Date
- 2019-01-08
- Last Posted Date
- 2025-05-15
- Target Recruit Count
- 230
- Registration Number
- NCT03796884
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇺🇸VA Puget Sound Health Care Sysem, Seattle, Washington, United States
Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma
- Conditions
- Uveal Melanoma
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2023-01-06
- Target Recruit Count
- 3
- Registration Number
- NCT03712904
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 32
- Next